Low or high doses of cefquinome targeting low or high bacterial inocula cure Klebsiella pneumoniae lung infections but differentially impact the levels of antibiotic resistance in fecal flora.

Archive ouverte

Vasseur, Maleck V. | Laurentie, Michel | Rolland, Jean-Guy | Perrin-Guyomard, Agnès | Henri, Jérôme | Ferran, Aude A | Toutain, Pierre-Louis | Bousquet‐mélou, Alain

Edité par CCSD ; American Society for Microbiology -

The combination of efficacious treatment against bacterial infections and mitigation of antibiotic resistance amplification in gut microbiota is a major challenge for antimicrobial therapy in food-producing animals. In rats, we evaluated the impact of cefquinome, a fourth-generation cephalosporin, on both Klebsiella pneumoniae lung infection and intestinal flora harboring CTX-M-producing Enterobacteriaceae. Germfree rats received a fecal flora specimen from specific-pathogen-free pigs, to which a CTX-M-producing Escherichia coli strain had been added. K. pneumoniae cells were inoculated in the lungs of these gnotobiotic rats by using either a low (10(5) CFU) or a high (10(9) CFU) inoculum. Without treatment, all animals infected with the low or high K. pneumoniae inoculum developed pneumonia and died before 120 h postchallenge. In the treated groups, the low-inoculum rats received a 4-day treatment of 5 mg/kg of body weight cefquinome beginning at 24 h postchallenge (prepatent phase of the disease), and the high-inoculum rats received a 4-day treatment of 50 mg/kg cefquinome beginning when the animals expressed clinical signs of infection (patent phase of the disease). The dose of 50 mg/kg targeting the high K. pneumoniae inoculum cured all the treated rats and resulted in a massive amplification of CTX-M-producing Enterobacteriaceae. A dose of 5 mg/kg targeting the low K. pneumoniae inoculum cured all the rats and averted an outbreak of clinical disease, all without any amplification of CTX-M-producing Enterobacteriaceae. These findings might have implications for the development of new antimicrobial treatment strategies that ensure a cure for bacterial infections while avoiding the amplification of resistance genes of human concern in the gut microbiota of food-producing animals.

Consulter en ligne

Suggestions

Du même auteur

Détermination de nouvelles modalités d'utilisation des bêta-lactamines en médecine vétérinaire par des approches PK/PD en vue de la protection de la santé publique: impIication de la taille de la charge bactérienne pathogène.

Archive ouverte | Vasseur, Maleck V. | CCSD

Au cours des dernières années, le microbiote intestinal de l'Homme et des animaux a été identifié comme étant le principal réservoir potentiel de gènes de résistance aux antibiotiques pouvant potentiellement être transmis aux path...

Differential activity of veterinary antibiotics on target pathogens versus digestive flora: development of a pharmacodynamic selectivity index for public health perspective

Archive ouverte | Vasseur, Maleck V. | CCSD

International audience

Early versus later antibiotic treatments of pulmonary infections. A strategy to conciliate control of infectious diseases and reduction of antibiotic consumption

Archive ouverte | Bousquet‐mélou, Alain | CCSD

International audience

Chargement des enrichissements...